These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 13819425)

  • 1. Measurement of antipyrine in plasma: interference by certain drugs.
    EDWARDS KD
    Aust J Exp Biol Med Sci; 1959 Aug; 37():391-8. PubMed ID: 13819425
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the half-life of antipyrine in plasma, whole blood and saliva of man.
    van Boxtel CJ; Wilson JT; Lindgren S; Sjöqvist F
    Eur J Clin Pharmacol; 1976 Feb; 9(4):327-32. PubMed ID: 971716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
    Vesell ES; Page JG
    J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A colorimetric micromethod for the estimation of antipyrine in plasma or serum.
    MENDELSOHN D; LEVIN NW
    S Afr J Med Sci; 1960 Apr; 25():13-8. PubMed ID: 13853922
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of exercise and adrenaline infusion upon the blood levels of propranolol and antipyrine in the horse.
    Powis G; Snow DH
    J Pharmacol Exp Ther; 1978 Jun; 205(3):725-31. PubMed ID: 660540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma antipyrine half-life can be determined from urine data.
    Atiba JO; Taylor G; Pershe RA; Blaschke TF
    Br J Clin Pharmacol; 1987 Jun; 23(6):715-9. PubMed ID: 2440468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of antipyrine kinetics by measurement in saliva.
    Fraser HS; Mucklow JC; Murray S; Davies DS
    Br J Clin Pharmacol; 1976 Apr; 3(2):321-5. PubMed ID: 973966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate decrease by hydrocortisone of the plasma half-life of antipyrine.
    Breckenridge A; Burke CW; Davies DS; Orme ML
    Br J Pharmacol; 1973 Feb; 47(2):434-6. PubMed ID: 4722054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic interpretation of steady state concentration of antipyrine and other drugs in plasma.
    Levy G
    Br J Clin Pharmacol; 1977 Feb; 4(1):89-90. PubMed ID: 843428
    [No Abstract]   [Full Text] [Related]  

  • 10. Antipyrine kinetics following influenza vaccination.
    Simonet R; Descotes J; Evreux JC
    Int J Clin Pharmacol Res; 1986; 6(3):231-3. PubMed ID: 3744625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrophotometric assay of antipyrine in plasma: a reevaluation.
    Greenblatt DJ; Locniskar A
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):401-4. PubMed ID: 500262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High speed liquid chromatography, 14C-radioassay and spectrophotometry for measuring antipyrine plasma half-life in rhesus monkeys (Macaca mulatta).
    Clark CR; Krieger RI; Miller JL
    Pharmacology; 1978; 17(2):98-103. PubMed ID: 98774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsomal enzymes in malnutrition as determined by plasma half life of antipyrine.
    Krishnaswamy K; Naidu AN
    Br Med J; 1977 Feb; 1(6060):538-40. PubMed ID: 843795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The absence of significant biliary excretion of antipyrine or its metabolites in humans.
    Wissel PS; Kappas A
    Clin Pharmacol Ther; 1987 Jan; 41(1):85-7. PubMed ID: 3802711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous analysis of antipyrine and lorazepam by high-performance liquid chromatography.
    Riley CA; Evans WE
    J Chromatogr; 1986 Oct; 382():199-205. PubMed ID: 3782386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The plasma half-life of antipyrine in chromic uraemic and normal subjects.
    Maddocks JL; Wake CJ; Harber MJ
    Br J Clin Pharmacol; 1975 Aug; 2(4):339-43. PubMed ID: 1233993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of vitamin C to affect the pharmacokinetic profile of antipyrine in man.
    Wilson JT; Boxtel CJ; Alvan G; Sjoqvist F
    J Clin Pharmacol; 1976; 16(5-6):265-70. PubMed ID: 1262536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of aryl hydrocarbon hydroxylase activity of human lymphocyte cultures and plasma elimination rates for antipyrine and phenylbutazone.
    Kellermann G; Luyten-Kellermann M; Horning M; Stafford M
    Drug Metab Dispos; 1975; 3(1):47-50. PubMed ID: 234834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microfilter paper method for antipyrine determination in whole blood by high pressure liquid chromatography.
    Loche S; Rifkind AB; Stoner E; Faedda A; Garabedian MC; New MI
    Ther Drug Monit; 1986; 8(2):214-8. PubMed ID: 3726938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipyrine kinetics following tetanus vaccination.
    Descotes J; Simonet R; Evreux JC
    Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):625-6. PubMed ID: 3793297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.